Last news
Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Jan. 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

TORRAS to Showcase Pioneering Personal Air-Conditioning Cooling Tech and More at CES 2025

TORRAS to Showcase Pioneering Personal Air-Conditioning Cooling Tech and More at CES 2025

HONG KONG, Jan. 3, 2025 /PRNewswire/ -- TORRAS, a pioneering consumer electronics and accessories brand, will participate in CES 2025, the world's largest electronics trade conference from January 7-10, 2025. At TORRAS' booth (#30847, South Hall 1),...

Govee Partners with IDC to Discuss the Impact of Smart Lighting and the Future of Smart Living In a New Whitepaper

Govee Partners with IDC to Discuss the Impact of Smart Lighting and the Future of Smart Living In a New Whitepaper

In new research for CES 2025, Govee aims to illuminate the next generation of smart lighting solutions LAS VEGAS, Jan. 3, 2025 /PRNewswire/ -- Govee, a global leader in smart ambient lighting innovation, in collaboration with International Data...

DataLend: 2024 Securities Lending Revenue Down 10% YoY to $9.64 Billion

DataLend: 2024 Securities Lending Revenue Down 10% YoY to $9.64 Billion

Lending revenue dips against backdrop of record-high indices NEW YORK, Jan. 3, 2025 /PRNewswire/ -- The global securities finance industry generated $9.64 billion in revenue for lenders in 2024, according to DataLend, the market data service of...

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across North America, Asia, Europe and the Middle East NEWPORT BEACH, Calif., Jan. 3, 2025 /PRNewswire/ -- CathWorks, a global leader in medical device digital health innovations, announced...

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN, China, Jan. 3, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases, today announced the first patient...

DXC Technology Names Brad Novak as Chief Information Officer

DXC Technology Names Brad Novak as Chief Information Officer

Veteran Technology Executive Joins DXC's Leadership Team ASHBURN, Va., Jan. 3, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Brad Novak as Chief...

Lexar to Showcase an Extensive Lineup of Products for Photographers, Filmmakers, and Gamers at CES 2025

Lexar to Showcase an Extensive Lineup of Products for Photographers, Filmmakers, and Gamers at CES 2025

SAN JOSE, Calif., Jan. 3, 2025 /PRNewswire/ -- Lexar, a leading global brand of flash memory solutions, is excited to announce their upcoming lineup to be shared at CES 2025 in Las Vegas. One spotlight of the show will be their Professional Workflow...

1 ... 55 56 57 58 59 60 61 62 63 ... 1588
menu
menu